Employing the Xiantao platform (xiantaozi.com), our observations revealed that TAF4B expression was generally subdued across a spectrum of cancer tissues, including BCa (Figure 1E), and displayed variability in expression levels correlating with different stages and subtypes of bladder cancer (Figure 1F). This evidence concerns the gene TAF4B and urinary bladder carcinoma.